[Previous Months][Date Index][Thread Index][Join - Register][Login]
[Message Prev][Message Next][Thread Prev][Thread Next]

[IP] RE: insulin-pumpers-digest V4 #967



_______________________________________________________________________
     >>>   MEDSCAPE's Diabetes and Endocrinology MedPulse(R)   <<<
                      http://diabetes.medscape.com
_______________________________________________________________________

NOVARTIS LAUNCHES STARLIX TO CONTROL GLUCOSE SPIKES IN TYPE 2 DIABETES
Novartis Pharmaceuticals announced on Monday that it has launched
Starlix (nateglinide) for the treatment of type 2 diabetes.
http://diabetes.medscape.com/34873.rhtml?srcmp=endo-031601
<a href="http://diabetes.medscape.com/34873.rhtml?srcmp=endo-031601">
Read it Here</a>

SIMPLE TESTS SCREEN FOR PERIPHERAL NEUROPATHY IN DIABETIC PATIENTS
Three simple tests can quickly screen diabetic patients for peripheral
neuropathy, according to a report in the February issue of Diabetes
Care.
http://diabetes.medscape.com/34824.rhtml?srcmp=endo-031601
<a href="http://diabetes.medscape.com/34824.rhtml?srcmp=endo-031601">
Read it Here</a>

ORALLY BIOAVAILABLE INSULIN PREPARATION OFFERS PHYSIOLOGIC GLUCOSE
CONTROL
An oral insulin preparation is 'revolutionary' in its capacity to be
absorbed across the intestinal wall and to provide physiologic control
of blood glucose levels in diabetic patients akin to that seen in
nondiabetic subjects.
http://diabetes.medscape.com/34860.rhtml?srcmp=endo-031601
<a href="http://diabetes.medscape.com/34860.rhtml?srcmp=endo-031601">
Read it Here</a>

LA TIMES: FDA OFFICIALS, WARNER-LAMBERT KNEW OF REZULIN RISKS
Warner-Lambert downplayed the potentially fatal risks associated with
Rezulin during the approval process and received help from federal drug
regulators in pushing the drug toward marketing approval, according to
an article published in Sunday's edition of the Los Angeles Times.
http://diabetes.medscape.com/34881.rhtml?srcmp=endo-031601
<a href="http://diabetes.medscape.com/34881.rhtml?srcmp=endo-031601">
Read it Here</a>

INSULIN DETEMIR MAY PROVIDE MORE PREDICTABLE GLUCOSE LEVELS THAN NPH
INSULIN
Insulin detemir, a soluble basal insulin analog, may provide more
predictable fasting blood glucose levels than NPH formulations,
according to a report published in the February issue of Diabetes Care.
http://diabetes.medscape.com/35063.rhtml?srcmp=endo-031601
<a href="http://diabetes.medscape.com/35063.rhtml?srcmp=endo-031601">
Read it Here</a>


Shop online without a credit card
http://www.rocketcash.com
RocketCash, a NetZero subsidiary
----------------------------------------------------------
for HELP or to subscribe/unsubscribe, contact: HELP@insulin-pumpers.org
send a DONATION http://www.Insulin-Pumpers.org/donate.shtml